nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—Cold symptoms—Octreotide—thymus cancer	0.0419	0.0489	CcSEcCtD
Paroxetine—HTR2A—phrenic nerve—thymus cancer	0.0384	0.268	CbGeAlD
Paroxetine—Hypertension worsened—Octreotide—thymus cancer	0.0241	0.0281	CcSEcCtD
Paroxetine—Prostatitis—Octreotide—thymus cancer	0.0241	0.0281	CcSEcCtD
Paroxetine—Breast neoplasm—Octreotide—thymus cancer	0.0174	0.0203	CcSEcCtD
Paroxetine—Breast feeding—Octreotide—thymus cancer	0.015	0.0176	CcSEcCtD
Paroxetine—Goitre—Octreotide—thymus cancer	0.0147	0.0172	CcSEcCtD
Paroxetine—Varicose vein—Octreotide—thymus cancer	0.0141	0.0165	CcSEcCtD
Paroxetine—HTR2A—pulmonary artery—thymus cancer	0.0139	0.0973	CbGeAlD
Paroxetine—Hypochromic anaemia—Octreotide—thymus cancer	0.0136	0.0158	CcSEcCtD
Paroxetine—HTR2A—vein—thymus cancer	0.0127	0.0886	CbGeAlD
Paroxetine—Prostatic disorder—Octreotide—thymus cancer	0.0124	0.0144	CcSEcCtD
Paroxetine—Ulcerative stomatitis—Octreotide—thymus cancer	0.0114	0.0133	CcSEcCtD
Paroxetine—Pancreatitis acute—Octreotide—thymus cancer	0.0114	0.0133	CcSEcCtD
Paroxetine—Hernia—Octreotide—thymus cancer	0.0112	0.0131	CcSEcCtD
Paroxetine—Trauma—Octreotide—thymus cancer	0.011	0.0129	CcSEcCtD
Paroxetine—Rectal disorder—Octreotide—thymus cancer	0.0107	0.0125	CcSEcCtD
Paroxetine—Appetite absent—Octreotide—thymus cancer	0.0106	0.0123	CcSEcCtD
Paroxetine—Renal pain—Octreotide—thymus cancer	0.01	0.0117	CcSEcCtD
Paroxetine—Anorectal disorder—Octreotide—thymus cancer	0.01	0.0117	CcSEcCtD
Paroxetine—Ear disorder—Octreotide—thymus cancer	0.00974	0.0114	CcSEcCtD
Paroxetine—Multiple fractures—Octreotide—thymus cancer	0.00905	0.0106	CcSEcCtD
Paroxetine—Fracture—Octreotide—thymus cancer	0.00905	0.0106	CcSEcCtD
Paroxetine—Haemorrhoids—Octreotide—thymus cancer	0.00894	0.0104	CcSEcCtD
Paroxetine—TACR1—hematopoietic system—thymus cancer	0.00878	0.0614	CbGeAlD
Paroxetine—Transaminases increased—Octreotide—thymus cancer	0.00864	0.0101	CcSEcCtD
Paroxetine—Cholelithiasis—Octreotide—thymus cancer	0.00845	0.00987	CcSEcCtD
Paroxetine—Haematoma—Octreotide—thymus cancer	0.00836	0.00976	CcSEcCtD
Paroxetine—Hypothyroidism—Octreotide—thymus cancer	0.00819	0.00956	CcSEcCtD
Paroxetine—Galactorrhoea—Octreotide—thymus cancer	0.00811	0.00946	CcSEcCtD
Paroxetine—Peptic ulcer—Octreotide—thymus cancer	0.00786	0.00918	CcSEcCtD
Paroxetine—Menstrual disorder—Octreotide—thymus cancer	0.00771	0.009	CcSEcCtD
Paroxetine—Intestinal obstruction—Octreotide—thymus cancer	0.00771	0.009	CcSEcCtD
Paroxetine—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00771	0.009	CcSEcCtD
Paroxetine—Paranoia—Octreotide—thymus cancer	0.00771	0.009	CcSEcCtD
Paroxetine—Neuralgia—Octreotide—thymus cancer	0.00757	0.00883	CcSEcCtD
Paroxetine—Metrorrhagia—Octreotide—thymus cancer	0.00736	0.00859	CcSEcCtD
Paroxetine—Neuritis—Octreotide—thymus cancer	0.00704	0.00822	CcSEcCtD
Paroxetine—Herpes zoster—Octreotide—thymus cancer	0.00698	0.00815	CcSEcCtD
Paroxetine—Otitis media—Octreotide—thymus cancer	0.00675	0.00788	CcSEcCtD
Paroxetine—Nephrolithiasis—Octreotide—thymus cancer	0.00654	0.00763	CcSEcCtD
Paroxetine—Endocrine disorder—Octreotide—thymus cancer	0.00634	0.0074	CcSEcCtD
Paroxetine—Acne—Octreotide—thymus cancer	0.00625	0.00729	CcSEcCtD
Paroxetine—Neoplasm malignant—Octreotide—thymus cancer	0.00616	0.00718	CcSEcCtD
Paroxetine—Breast pain—Octreotide—thymus cancer	0.00603	0.00703	CcSEcCtD
Paroxetine—Amenorrhoea—Octreotide—thymus cancer	0.00598	0.00698	CcSEcCtD
Paroxetine—CHRM5—epithelium—thymus cancer	0.0059	0.0412	CbGeAlD
Paroxetine—Rectal haemorrhage—Octreotide—thymus cancer	0.00582	0.00679	CcSEcCtD
Paroxetine—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00578	0.00675	CcSEcCtD
Paroxetine—Arthropathy—Octreotide—thymus cancer	0.00578	0.00675	CcSEcCtD
Paroxetine—Cellulitis—Octreotide—thymus cancer	0.00578	0.00675	CcSEcCtD
Paroxetine—Herpes simplex—Octreotide—thymus cancer	0.0057	0.00666	CcSEcCtD
Paroxetine—Muscle twitching—Octreotide—thymus cancer	0.00535	0.00625	CcSEcCtD
Paroxetine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00526	0.00614	CcSEcCtD
Paroxetine—Vaginal inflammation—Octreotide—thymus cancer	0.00526	0.00614	CcSEcCtD
Paroxetine—Eructation—Octreotide—thymus cancer	0.00516	0.00603	CcSEcCtD
Paroxetine—Hyperkalaemia—Octreotide—thymus cancer	0.00516	0.00603	CcSEcCtD
Paroxetine—Cystitis noninfective—Octreotide—thymus cancer	0.00513	0.00599	CcSEcCtD
Paroxetine—TACR1—lung—thymus cancer	0.0051	0.0356	CbGeAlD
Paroxetine—Cystitis—Octreotide—thymus cancer	0.00508	0.00592	CcSEcCtD
Paroxetine—Candida infection—Octreotide—thymus cancer	0.00502	0.00586	CcSEcCtD
Paroxetine—Vaginal infection—Octreotide—thymus cancer	0.00496	0.00579	CcSEcCtD
Paroxetine—Neuropathy—Octreotide—thymus cancer	0.00494	0.00576	CcSEcCtD
Paroxetine—Bladder pain—Octreotide—thymus cancer	0.00475	0.00555	CcSEcCtD
Paroxetine—Urine output increased—Octreotide—thymus cancer	0.00475	0.00555	CcSEcCtD
Paroxetine—Mouth ulceration—Octreotide—thymus cancer	0.00475	0.00555	CcSEcCtD
Paroxetine—Hyperkinesia—Octreotide—thymus cancer	0.00458	0.00535	CcSEcCtD
Paroxetine—Phlebitis—Octreotide—thymus cancer	0.00443	0.00517	CcSEcCtD
Paroxetine—SLC6A3—hematopoietic system—thymus cancer	0.00442	0.0309	CbGeAlD
Paroxetine—Sleep disorder—Octreotide—thymus cancer	0.00441	0.00514	CcSEcCtD
Paroxetine—Thrombophlebitis—Octreotide—thymus cancer	0.00441	0.00514	CcSEcCtD
Paroxetine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00439	0.00512	CcSEcCtD
Paroxetine—Diabetes mellitus—Octreotide—thymus cancer	0.00439	0.00512	CcSEcCtD
Paroxetine—Polyuria—Octreotide—thymus cancer	0.00435	0.00507	CcSEcCtD
Paroxetine—Gastroenteritis—Octreotide—thymus cancer	0.00431	0.00502	CcSEcCtD
Paroxetine—Deafness—Octreotide—thymus cancer	0.00427	0.00498	CcSEcCtD
Paroxetine—Cardiac failure congestive—Octreotide—thymus cancer	0.00421	0.00491	CcSEcCtD
Paroxetine—Injury—Octreotide—thymus cancer	0.00415	0.00484	CcSEcCtD
Paroxetine—Amnesia—Octreotide—thymus cancer	0.00406	0.00474	CcSEcCtD
Paroxetine—SLC6A4—hematopoietic system—thymus cancer	0.00405	0.0283	CbGeAlD
Paroxetine—Visual disturbance—Octreotide—thymus cancer	0.00403	0.0047	CcSEcCtD
Paroxetine—Anaphylactoid reaction—Octreotide—thymus cancer	0.00394	0.0046	CcSEcCtD
Paroxetine—Arthritis—Octreotide—thymus cancer	0.00393	0.00458	CcSEcCtD
Paroxetine—Hypoglycaemia—Octreotide—thymus cancer	0.00391	0.00456	CcSEcCtD
Paroxetine—Osteoarthritis—Octreotide—thymus cancer	0.00382	0.00445	CcSEcCtD
Paroxetine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00382	0.00445	CcSEcCtD
Paroxetine—Psychotic disorder—Octreotide—thymus cancer	0.00373	0.00435	CcSEcCtD
Paroxetine—Dehydration—Octreotide—thymus cancer	0.00355	0.00414	CcSEcCtD
Paroxetine—Dry skin—Octreotide—thymus cancer	0.0035	0.00408	CcSEcCtD
Paroxetine—TACR1—lymph node—thymus cancer	0.00349	0.0244	CbGeAlD
Paroxetine—Cramp muscle—Octreotide—thymus cancer	0.00344	0.00401	CcSEcCtD
Paroxetine—Nasopharyngitis—Octreotide—thymus cancer	0.00341	0.00398	CcSEcCtD
Paroxetine—Gastritis—Octreotide—thymus cancer	0.00338	0.00394	CcSEcCtD
Paroxetine—Muscular weakness—Octreotide—thymus cancer	0.00337	0.00393	CcSEcCtD
Paroxetine—Asthma—Octreotide—thymus cancer	0.0033	0.00385	CcSEcCtD
Paroxetine—Influenza—Octreotide—thymus cancer	0.0033	0.00385	CcSEcCtD
Paroxetine—Pancreatitis—Octreotide—thymus cancer	0.00323	0.00377	CcSEcCtD
Paroxetine—Sweating increased—Octreotide—thymus cancer	0.00321	0.00375	CcSEcCtD
Paroxetine—Bronchitis—Octreotide—thymus cancer	0.00317	0.0037	CcSEcCtD
Paroxetine—Dysuria—Octreotide—thymus cancer	0.00308	0.0036	CcSEcCtD
Paroxetine—Pollakiuria—Octreotide—thymus cancer	0.00305	0.00356	CcSEcCtD
Paroxetine—Weight increased—Octreotide—thymus cancer	0.003	0.0035	CcSEcCtD
Paroxetine—Weight decreased—Octreotide—thymus cancer	0.00298	0.00348	CcSEcCtD
Paroxetine—Hyperglycaemia—Octreotide—thymus cancer	0.00298	0.00347	CcSEcCtD
Paroxetine—Pneumonia—Octreotide—thymus cancer	0.00296	0.00345	CcSEcCtD
Paroxetine—Drowsiness—Octreotide—thymus cancer	0.00294	0.00343	CcSEcCtD
Paroxetine—Depression—Octreotide—thymus cancer	0.00293	0.00342	CcSEcCtD
Paroxetine—CYP2C8—hematopoietic system—thymus cancer	0.00293	0.0205	CbGeAlD
Paroxetine—Neuropathy peripheral—Octreotide—thymus cancer	0.00288	0.00336	CcSEcCtD
Paroxetine—HTR2A—neck—thymus cancer	0.00288	0.0201	CbGeAlD
Paroxetine—Jaundice—Octreotide—thymus cancer	0.00287	0.00335	CcSEcCtD
Paroxetine—Conjunctivitis—Octreotide—thymus cancer	0.00286	0.00334	CcSEcCtD
Paroxetine—Urinary tract infection—Octreotide—thymus cancer	0.00286	0.00334	CcSEcCtD
Paroxetine—Haematuria—Octreotide—thymus cancer	0.0028	0.00327	CcSEcCtD
Paroxetine—Hepatobiliary disease—Octreotide—thymus cancer	0.00278	0.00325	CcSEcCtD
Paroxetine—Epistaxis—Octreotide—thymus cancer	0.00277	0.00324	CcSEcCtD
Paroxetine—Sinusitis—Octreotide—thymus cancer	0.00276	0.00322	CcSEcCtD
Paroxetine—Bradycardia—Octreotide—thymus cancer	0.00269	0.00314	CcSEcCtD
Paroxetine—Rhinitis—Octreotide—thymus cancer	0.00265	0.00309	CcSEcCtD
Paroxetine—Hepatitis—Octreotide—thymus cancer	0.00264	0.00308	CcSEcCtD
Paroxetine—Hypoaesthesia—Octreotide—thymus cancer	0.00263	0.00307	CcSEcCtD
Paroxetine—CYP2B6—hematopoietic system—thymus cancer	0.00263	0.0183	CbGeAlD
Paroxetine—Pharyngitis—Octreotide—thymus cancer	0.00262	0.00306	CcSEcCtD
Paroxetine—Oedema peripheral—Octreotide—thymus cancer	0.0026	0.00303	CcSEcCtD
Paroxetine—CYP2C9—hematopoietic system—thymus cancer	0.0026	0.0182	CbGeAlD
Paroxetine—SLC6A3—lung—thymus cancer	0.00257	0.0179	CbGeAlD
Paroxetine—Visual impairment—Octreotide—thymus cancer	0.00254	0.00297	CcSEcCtD
Paroxetine—Tinnitus—Octreotide—thymus cancer	0.00246	0.00287	CcSEcCtD
Paroxetine—Flushing—Octreotide—thymus cancer	0.00245	0.00286	CcSEcCtD
Paroxetine—Cardiac disorder—Octreotide—thymus cancer	0.00245	0.00286	CcSEcCtD
Paroxetine—Immune system disorder—Octreotide—thymus cancer	0.00238	0.00278	CcSEcCtD
Paroxetine—Arrhythmia—Octreotide—thymus cancer	0.00236	0.00275	CcSEcCtD
Paroxetine—SLC6A4—lung—thymus cancer	0.00235	0.0164	CbGeAlD
Paroxetine—CHRM1—lung—thymus cancer	0.00234	0.0164	CbGeAlD
Paroxetine—Alopecia—Octreotide—thymus cancer	0.00233	0.00272	CcSEcCtD
Paroxetine—Mental disorder—Octreotide—thymus cancer	0.00231	0.0027	CcSEcCtD
Paroxetine—CHRM3—thyroid gland—thymus cancer	0.00231	0.0161	CbGeAlD
Paroxetine—Erythema—Octreotide—thymus cancer	0.0023	0.00268	CcSEcCtD
Paroxetine—Malnutrition—Octreotide—thymus cancer	0.0023	0.00268	CcSEcCtD
Paroxetine—Flatulence—Octreotide—thymus cancer	0.00226	0.00264	CcSEcCtD
Paroxetine—Tension—Octreotide—thymus cancer	0.00226	0.00263	CcSEcCtD
Paroxetine—Nervousness—Octreotide—thymus cancer	0.00223	0.0026	CcSEcCtD
Paroxetine—Back pain—Octreotide—thymus cancer	0.00222	0.00259	CcSEcCtD
Paroxetine—Muscle spasms—Octreotide—thymus cancer	0.00221	0.00258	CcSEcCtD
Paroxetine—CYP2C8—pituitary gland—thymus cancer	0.00217	0.0152	CbGeAlD
Paroxetine—Vision blurred—Octreotide—thymus cancer	0.00217	0.00253	CcSEcCtD
Paroxetine—Tremor—Octreotide—thymus cancer	0.00215	0.00251	CcSEcCtD
Paroxetine—HTR2A—hematopoietic system—thymus cancer	0.00214	0.015	CbGeAlD
Paroxetine—Ill-defined disorder—Octreotide—thymus cancer	0.00213	0.00249	CcSEcCtD
Paroxetine—Anaemia—Octreotide—thymus cancer	0.00212	0.00248	CcSEcCtD
Paroxetine—Agitation—Octreotide—thymus cancer	0.00211	0.00246	CcSEcCtD
Paroxetine—Malaise—Octreotide—thymus cancer	0.00207	0.00242	CcSEcCtD
Paroxetine—SLC6A2—lung—thymus cancer	0.00207	0.0145	CbGeAlD
Paroxetine—Vertigo—Octreotide—thymus cancer	0.00206	0.00241	CcSEcCtD
Paroxetine—Syncope—Octreotide—thymus cancer	0.00206	0.00241	CcSEcCtD
Paroxetine—Palpitations—Octreotide—thymus cancer	0.00203	0.00237	CcSEcCtD
Paroxetine—Loss of consciousness—Octreotide—thymus cancer	0.00202	0.00236	CcSEcCtD
Paroxetine—Cough—Octreotide—thymus cancer	0.00201	0.00234	CcSEcCtD
Paroxetine—Convulsion—Octreotide—thymus cancer	0.00199	0.00232	CcSEcCtD
Paroxetine—Hypertension—Octreotide—thymus cancer	0.00198	0.00232	CcSEcCtD
Paroxetine—HTR2A—epithelium—thymus cancer	0.00196	0.0137	CbGeAlD
Paroxetine—Arthralgia—Octreotide—thymus cancer	0.00196	0.00228	CcSEcCtD
Paroxetine—Chest pain—Octreotide—thymus cancer	0.00196	0.00228	CcSEcCtD
Paroxetine—Myalgia—Octreotide—thymus cancer	0.00196	0.00228	CcSEcCtD
Paroxetine—CYP2D6—hematopoietic system—thymus cancer	0.00195	0.0136	CbGeAlD
Paroxetine—Anxiety—Octreotide—thymus cancer	0.00195	0.00228	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00194	0.00227	CcSEcCtD
Paroxetine—Discomfort—Octreotide—thymus cancer	0.00193	0.00226	CcSEcCtD
Paroxetine—Dry mouth—Octreotide—thymus cancer	0.00191	0.00223	CcSEcCtD
Paroxetine—Anaphylactic shock—Octreotide—thymus cancer	0.00188	0.00219	CcSEcCtD
Paroxetine—Oedema—Octreotide—thymus cancer	0.00188	0.00219	CcSEcCtD
Paroxetine—Infection—Octreotide—thymus cancer	0.00186	0.00217	CcSEcCtD
Paroxetine—CYP2B6—lymphoid tissue—thymus cancer	0.00185	0.0129	CbGeAlD
Paroxetine—Shock—Octreotide—thymus cancer	0.00185	0.00215	CcSEcCtD
Paroxetine—Nervous system disorder—Octreotide—thymus cancer	0.00184	0.00215	CcSEcCtD
Paroxetine—Thrombocytopenia—Octreotide—thymus cancer	0.00184	0.00214	CcSEcCtD
Paroxetine—Tachycardia—Octreotide—thymus cancer	0.00183	0.00214	CcSEcCtD
Paroxetine—Skin disorder—Octreotide—thymus cancer	0.00182	0.00213	CcSEcCtD
Paroxetine—Hyperhidrosis—Octreotide—thymus cancer	0.00181	0.00212	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00171	0.00199	CcSEcCtD
Paroxetine—Insomnia—Octreotide—thymus cancer	0.0017	0.00198	CcSEcCtD
Paroxetine—Paraesthesia—Octreotide—thymus cancer	0.00168	0.00197	CcSEcCtD
Paroxetine—Dyspnoea—Octreotide—thymus cancer	0.00167	0.00195	CcSEcCtD
Paroxetine—Somnolence—Octreotide—thymus cancer	0.00167	0.00195	CcSEcCtD
Paroxetine—Dyspepsia—Octreotide—thymus cancer	0.00165	0.00193	CcSEcCtD
Paroxetine—Decreased appetite—Octreotide—thymus cancer	0.00163	0.0019	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00162	0.00189	CcSEcCtD
Paroxetine—Fatigue—Octreotide—thymus cancer	0.00162	0.00189	CcSEcCtD
Paroxetine—Pain—Octreotide—thymus cancer	0.0016	0.00187	CcSEcCtD
Paroxetine—Constipation—Octreotide—thymus cancer	0.0016	0.00187	CcSEcCtD
Paroxetine—HTR2A—pituitary gland—thymus cancer	0.00159	0.0111	CbGeAlD
Paroxetine—Feeling abnormal—Octreotide—thymus cancer	0.00155	0.0018	CcSEcCtD
Paroxetine—Gastrointestinal pain—Octreotide—thymus cancer	0.00153	0.00179	CcSEcCtD
Paroxetine—CYP2B6—lung—thymus cancer	0.00152	0.0107	CbGeAlD
Paroxetine—Urticaria—Octreotide—thymus cancer	0.00149	0.00174	CcSEcCtD
Paroxetine—Body temperature increased—Octreotide—thymus cancer	0.00148	0.00173	CcSEcCtD
Paroxetine—Abdominal pain—Octreotide—thymus cancer	0.00148	0.00173	CcSEcCtD
Paroxetine—SLC6A2—lymph node—thymus cancer	0.00142	0.00989	CbGeAlD
Paroxetine—ABCB1—hematopoietic system—thymus cancer	0.0014	0.00981	CbGeAlD
Paroxetine—Hypersensitivity—Octreotide—thymus cancer	0.00138	0.00161	CcSEcCtD
Paroxetine—Asthenia—Octreotide—thymus cancer	0.00135	0.00157	CcSEcCtD
Paroxetine—Pruritus—Octreotide—thymus cancer	0.00133	0.00155	CcSEcCtD
Paroxetine—Diarrhoea—Octreotide—thymus cancer	0.00128	0.0015	CcSEcCtD
Paroxetine—ABCB1—epithelium—thymus cancer	0.00128	0.00897	CbGeAlD
Paroxetine—HTR2A—lung—thymus cancer	0.00124	0.00869	CbGeAlD
Paroxetine—Dizziness—Octreotide—thymus cancer	0.00124	0.00145	CcSEcCtD
Paroxetine—Vomiting—Octreotide—thymus cancer	0.00119	0.00139	CcSEcCtD
Paroxetine—Rash—Octreotide—thymus cancer	0.00118	0.00138	CcSEcCtD
Paroxetine—Dermatitis—Octreotide—thymus cancer	0.00118	0.00138	CcSEcCtD
Paroxetine—Headache—Octreotide—thymus cancer	0.00117	0.00137	CcSEcCtD
Paroxetine—Nausea—Octreotide—thymus cancer	0.00111	0.0013	CcSEcCtD
Paroxetine—ABCB1—pituitary gland—thymus cancer	0.00104	0.00728	CbGeAlD
Paroxetine—ABCB1—lymphoid tissue—thymus cancer	0.000988	0.00691	CbGeAlD
Paroxetine—ABCB1—bone marrow—thymus cancer	0.0009	0.00629	CbGeAlD
Paroxetine—ABCB1—thyroid gland—thymus cancer	0.000897	0.00627	CbGeAlD
Paroxetine—ABCB1—lung—thymus cancer	0.000815	0.0057	CbGeAlD
Paroxetine—ABCB1—lymph node—thymus cancer	0.000557	0.0039	CbGeAlD
